uniQure
QURE
#5392
Rank
โ‚ฌ1.16 B
Marketcap
18,66ย โ‚ฌ
Share price
1.86%
Change (1 day)
170.14%
Change (1 year)

Revenue for uniQure (QURE)

Revenue in 2025 (TTM): โ‚ฌ14.08 Million

According to uniQure's latest financial reports the company's current revenue (TTM ) is โ‚ฌ13.53 Million. In 2024 the company made a revenue of โ‚ฌ26.06 Million an increase over the revenue in the year 2023 that were of โ‚ฌ14.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for uniQure from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ14.08 M-45.96%
2024 โ‚ฌ26.06 M81.84%
2023 โ‚ฌ14.33 M-85.56%
2022 โ‚ฌ99.26 M-78.55%
2021 โ‚ฌ0.46 B1417.06%
2020 โ‚ฌ30.49 M369.25%
2019 โ‚ฌ6.49 M-34.11%
2018 โ‚ฌ9.86 M-9.7%
2017 โ‚ฌ10.92 M-54.06%
2016 โ‚ฌ23.77 M153.61%
2015 โ‚ฌ9.37 M92.59%
2014 โ‚ฌ4.86 M66.94%
2013 โ‚ฌ2.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ30.90 B 228,272.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ28.24 M 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ89.3 M 559.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚ฌ17.92 M 32.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.82 B 301,627.39%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.65 B 19,543.20%๐Ÿ‡บ๐Ÿ‡ธ USA